Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
There is no reason to continue beyond clinical resolution
28 note to investors, William Blair analysts wrote that Applied Therapeutics suspects the CRL was related to the efficacy package as opposed to [chemistry, manufacturing and controls] or safety. Results from the Phase III ACTION-Galactosemia Kids study, unveiled in April 2023, showed that govorestat fell short of its primary efficacy endpoint, a composite of four clinical measures designed to assess various domains of galactosemia symptoms
Pan T, Wang N, et,al
According to the changes in endogenous HGF expression levels, liver regeneration can be divided into two stages
US$ 20.43
US$ 24.12
US$ 23.47
US$ 25.05
US$ 27.14
US$ 25.06
